Τόμος 19 (2005) – Τεύχος 2 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 19 (2005) – Issue 2 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

 

Title Knowledge and attitude of young adults regarding cutaneous malignant melanoma: a study of two hundred students of the faculty of health and caring professions
Authors Fragiski Anthouli¹, Maria Parava², Melpomeni Stoikidou¹, Helen Plessa³, Despina Dessou¹, Alice Anagnostopoulou and Demitra Soubala¹

1. Faculty of Health and Caring Professions, Technological Educational Institute (T.E.I.A.), Athens, Greece

2. Peripheral Infirmary Terpyllou, General Hospital of Kilkis

3. School of Business Administration and Economics, Technological Educational Institute (T.E.I.A.), Athens, Greece

4. Faculty of Applied Mathematics and Physics, National Technical University of Athens (N.T.U.A.), Athens, Greece

Citation Anthouli, F., Parava, M., Stoikidou, M., Plessa, H., Dessou, D. et al.: Knowledge and attitude of young adults regarding cutaneous malignant melanoma: a study of two hundred students of the faculty of health and caring professions, Epitheorese Klin. Farmakol. Farmakokinet. 19(2): 77-86 (2005)
Publication Date Received for publication: : 2 February 2005

 Accepted for publication: 12 May 2005

Full Text Language English
Order – Buy Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Cutaneous Malignant Melanoma (CMM), risk factors, prevention, diagnosis, Health Care Visiting Department, Nursing Department, student knowledge status, consequences of solar radiation, Incidence and mortality of cutaneous malignant melanoma.
Other Terms review article
Summary  Cutaneous malignant melanoma (CMM) accounts for the large majority of deaths from skin cancer in young (20-44 years) and middle-aged (45-64 years) adults. Being strongly associated with intense and intermittent sun exposure, particularly in early life, CMM is a potentially preventable neoplasm and it is also effectively treated provided that early diagnosis of thin lesions is available. With a principal objective of the examination of knowledge of the dangers of solar radiation in young people, became an effort of evaluation of the knowledge of Nursing Faculties (Department of the Faculty of Health and Caring Professions of Educational Institute of Athens (T.E.I.A.) with regard to cutaneous malignant melanoma (CMM). The research was carried out on 200 students of the two departments and concerned only the two first (1st + 2nd) and the two last (6th +7th) semesters aiming at the comparison of the level of their knowledge. The methods used for the research based upon questionnaires, working with multiple choice questions referring to diagnosis, risk factors and prevention of malignant melanoma. The results of the research showed that either the students of the first two or of the last two semesters of both departments presented a poor level of knowledge with regard to malignant melanoma (44% and 48% and 44% and 39% respectively), while on the contrary, a small percentage of students, regardless of semester and department had a very good knowledge status varying from 4%-8%.More analytically, all the students regardless of Department and Semester appear to present a better level of knowledge in the prevention of melanoma (62%-71%), a rather good level of knowledge of the risk factors for the development of malignant melanoma (53%-61%), white the worst level of knowledge is observed in the field of diagnosis of malignant melanoma (42%-54%). In general, the students of both departments of the Faculty of Health and Caring Professions appear to have insufficient knowledge concerning cutaneous malignant melanoma. The reasons that lead to this knowledge status regarding CMM, is that skin cancer including CMM isn’t overemphasized, like other forms of cancer such as cancers of breast, lung, or cervix. Noteworthy in the above study regarding CMM, is that the students of the first two (1st +2nd) Semesters of Health Visiting Department had a more sufficient knowledge about malignant melanoma’s risks factors than the two last (6th +7th). This could be a result of a higher awareness during the last years, due to a high melanoma cancer incidence and mortality in northern Europe countries, like Greece. Likewise, the recent preventive campaigns and intervention programs in schools upon the dangers which intense exposure to solar radiation could cause, support the students of the first semesters with earlier information and sensitization regarding the risk factors for CMM development, resulting in a better awareness than the students of the last Semesters.
References 1.    Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Piconi O., Boyle P.t et al: Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer 41: 45-60 (2005)

2.    Elder D.E.: Skin cancer. Cancer 75: 245-256 (1995)

3.    Desmond R.A., Soong S.: Epidemiology of malignant melanoma. Surg. Clin. North America 83: 1-29 (2003)

4.    Marks R.: An overview of skin cancers. Incidence and causation. Cancer 75: 607-612 (1995)

5.    Kraemer K. H.: Sunlight and skin cancer: Another link revealed. Proc. Natl. Acad. Sci. (USA) 94: 11-14 (1997)

6.    Geller A.C., Annas G.D.: Epidemiology of melanoma and nonmelanoma skin cancer. Sem. Oncol. Nurs. 70: 766-72 (1995)

7.    Anthouli-Anagnostopoulou F.A., Kanellos E., Hatziolou E., et al.: Morpheaform basal cell carcinoma. Histopathological study of 769 cases and review of the literature. Rev. Clin. Pharmacol. Pharmacokinet. Intern. Edition 15: 43-49 (2001)

8.    Anthouli-Anagnostopoulou F.A.: Prognostic factors in Morphean Basal cell carcinoma of the skin. A clinicopathological study of 104 cases and review of the literature. Rev. Clin. Pharmacol. Pharmacokinet. Intern. Edition 15: 211-218 (2001)

9.    Anthouli-Anagnostopoulou Fr., Hatziolou E.: Recurrent Morphean Basal cell carcinoma of the skin. A clinicohistopathoiogical study of 97 cases. Adv. Clin. Path. 6: 17-24 (2002)

10.  www.edae.gr: Ελληνική Δερματολογική και Αφροδισιολογική Εταιρεία

11.  Staurianeas N.G., Agelakopoulos Ch.: Malignant melanoma. Modern Dermatological Oncology, Medical publications P. Ch. Paschalidis, p. 129-156, 2001

12.  Schaffer J., Rigel D., Kopf A., Bolognia J.: Cutaneous melanoma – Past, present, and future. J. Am. Acad. Dermatol. 51: 565-569 (2004)

13.  Streetly A., Markowe H.: Changing trends in epidemiology of malignant melanoma: gender differences and their implication for public health. Int. J. Epidemiol. 24: 897-907 (1995)

14.  Lee J.E.: Factors associated with melanoma incidence and prognosis. Semin. Surg .Oncol. 12: 379-385 (1996)

15.  Mackie R.M.: Incidence, risk factors and prevention of melanoma. Eur. J. Cancer 34: 53-56 (1993)

16.  Zettersten E., Shaikh L., Ramirez R., Sabet M.: Prognostic factors in primary cutaneous melanoma. Surg. Clinics North America 83: 61-75 (2003)

17.  Rodenas J.M., Delgado-Rodriguez M., Herranz M.T., Tercedor J., Serrano S.: Sun exposure, pigmentary traits and risk of cutaneous malignant melanoma. Cancer-causes-control 7: 275-283 (1996)

18.  Gandini S., Sera F., Cattaruzza M.S., et al: Meta-analysis of risk factors for cutaneous melanoma. I. Common and atypical naevi. Eur. J. Cancer 41: 28-44 (2005)

19.  Katsambas A., Nicolaidou E.: Cutaneous Malignant Melanoma and sun exposure. Arch. Dermatol. 132: 444- 450 (1996)

20.  Edwood M.J.: Melanoma and sun exposure. Semin. Oncol. 23: 650-666 (1995)

21.  Bito T., Oka M.: UV – induced skin damage. Toxicology 189(1-2): 21-39 (2003)

22.  Κίντζιου E., Πρωτόπατπτα E„ Τσαχαγέας Xρ., Σταυριανέας N., Πλέσσα E.: Ηλιακή ακτινοβολία και καρκίνος δέρματος: Σύντομη θεώρηση. Επιθ. Κλιν. Φαρμακολ. Φσρμακοκινητικής 20: 45-52 (2002)

23.  Πλέσσας Σ.Τ., Σουλιώτη Ε., Πλέσσας Χ.Τ.: Δεσοξυριβονουκλεϊνικά οξέα-DNA: Χρήσεις τους στην Κοσμετολογία και στη Θεραπευτική. Επιθ. Κλιν. Φαρμακολ. Φσρμακοκινητικής 3: 130-136 (1985)

24.  Thomas L., Lim H.W.: Sunscreens. J. Drugs Dermatol. 2: 174-177 (2003)

25.  Mahon S.M.: Skin cancer prevention: education and public health issues. Semin. Oncol. Nurs. 19: 52-61 (2003)

26.  Kefala V., Kostara I., Karageorgiou H., Varonos D.D.: In vitro model for the evaluation of Essential oils materials phototoxic activity. Rev. Clin. Pharmacol. Pharmacokinet. Intern. Edition 12: 53-57 (1998)

27.  Kefala V., Kostara I., Karageorgiou H., Varonos D.D.: In vitro model for the evaluation of sunscreen agents phototoxic activity. Rev. Clin. Pharmacol. Pharmacokinet. 12: 59-62 (1998)

28.  Kefala V., Kostara l., Karageorgiou H., Varonos D.D.: In vitro model for the evaluation of preservatives phototoxic activity. Rev. Clin. Pharmacol. Pharmacokinet. 14: 93-96 (2000)

29.  Diffey B.L.: The future incidence of cutaneous melanoma within U.K. Br. J. Dermatol. 151: 868-872 (2004)

30.  Rees J.L.: The melanoma epidemic: reality and artefact. Br. Med. J. 312: 137-138 (1996)

31.  Wesson K.M., Silverberg N.B.: Sun protection education in the United states: what we know and what needs to be taught. Cutis 71: 71-77 (2003)

32.  Veronesi V., Cascinelli N.: Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch. Surg. 126: 4341-4384 (1991)

33.  Bosetti C., La Vecchia C., Naldi L., Lucchini F., Negri E., Levi F.: Mortality from cutaneous malignant melanoma In Europe. Has the epidemic levelled of? Melanoma Res. 14: 301-309 (2004)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2005– ANNUAL SUBSCRIPTION 2005
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

 

Bookmark the permalink.

Comments are closed.